Weight Loss · Dual GIP/GLP-1 · Brandon, FL
The most effective FDA-approved weight loss medication available, a dual GIP/GLP-1 receptor agonist showing up to 22% average body weight reduction in clinical trials. A step up from semaglutide for patients who want maximum results.
Tirzepatide (brand names Mounjaro® and Zepbound®) is the first dual GIP and GLP-1 receptor agonist, activating two hormonal pathways simultaneously to produce greater weight loss than GLP-1 medications alone.
GLP-1 receptor agonists like semaglutide reduce appetite and slow gastric emptying. Tirzepatide does all of that, and also activates GIP (glucose-dependent insulinotropic polypeptide) receptors, which enhances insulin secretion, reduces glucagon, and appears to amplify the total weight loss effect. In the SURMOUNT-1 clinical trial, participants on tirzepatide lost an average of 20.9% of body weight at the highest dose over 72 weeks, making it the most effective approved weight loss medication available. At Florida Aesthetics, all tirzepatide programs are physician-supervised with regular check-ins to monitor progress and adjust dosing.
Tirzepatide is priced monthly. Costs vary based on dose. Most patients start at 2.5 mg and titrate up over 20 weeks. Ask about current pricing at your consultation.
2.5 mg · Weeks 1–4
consultation per month
5–15 mg · Most patients
consultation per month
Best value
consultation per month
Ready to Book?
Our physician will evaluate your health history and determine if tirzepatide is the right program for you. Schedule your complimentary consultation.